Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Vaccination with Mycobacterium: can it cure allergies?].

R Louis1

  • 1Service de Pneumologie, CHU Sart Tilman, Liège.

Revue Medicale De Liege
|August 30, 2003
PubMed
Summary

Bacillus Calmette-Guérin (BCG) vaccination and Mycobacterium vaccae administration show potential in preventing and treating allergic conditions like asthma and atopic dermatitis by modulating immune responses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Synbiotic Bactecal® reduces airway obstruction, sputum eosinophils and IL-4 but increases sputum IL-8 in patients with uncontrolled asthma" [Cytokine 202 (2026) 157145].

Cytokine·2026
Same author

Synbiotic Bactecal® reduces airway obstruction, sputum eosinophils and IL-4 but increases sputum IL-8 in patients with uncontrolled asthma.

Cytokine·2026
Same author

Author Correction: Forced oscillation technique in progressive pulmonary fibrosis in a single-center retrospective study.

Scientific reports·2026
Same author

Forced oscillation technique in progressive pulmonary fibrosis in a single-center retrospective study.

Scientific reports·2025
Same author

Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users.

Journal of investigational allergology & clinical immunology·2025
Same author

Increase in Blood Eosinophil Count Over Time and Sputum IL8 are Associated with FEV<sub>1</sub> Decline in Asthma.

Lung·2024

Area of Science:

  • Immunology
  • Microbiology
  • Allergology

Context:

  • Tuberculosis (TB) and allergy prevalence have inversely changed over the last century.
  • Tuberculosis involves a Th1 immune response, while allergy is characterized by a Th2 pattern.
  • Early-life Bacillus Calmette-Guérin (BCG) vaccination correlates with reduced childhood allergy prevalence.

Purpose:

  • To investigate the potential of mycobacterial interventions in mitigating allergic diseases.
  • To evaluate the efficacy of BCG and Mycobacterium vaccae in experimental asthma models.
  • To assess the therapeutic effect of Mycobacterium vaccae in pediatric atopic dermatitis.

Summary:

  • BCG vaccination in early life is linked to decreased allergy prevalence later in childhood.
  • In a mouse asthma model, BCG and killed Mycobacterium vaccae administration inhibited allergic sensitization, bronchial inflammation, and hyperresponsiveness.
  • Subcutaneous injection of killed Mycobacterium vaccae reduced the severity of skin lesions in children and adolescents with atopic dermatitis.

Impact:

  • Mycobacterial interventions, including BCG and Mycobacterium vaccae, demonstrate a promising immunomodulatory role in preventing and treating allergic diseases.
  • These findings suggest a potential therapeutic strategy for managing conditions like asthma and atopic dermatitis by harnessing the immune-modulating properties of mycobacteria.
  • Further research into mycobacterial therapies could lead to novel approaches for allergy management.

Related Experiment Videos